Study Evaluating MAC-321 in Colorectal Cancer
NCT00063427
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Neoplasms
Colonic Neoplasms
Rectal Neoplasms
Interventions
DRUG:
MAC-321
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer